Aura Biosciences, Inc.
AURA
$5.36
-$0.04-0.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.73% | -13.67% | -11.14% | -12.82% | -33.65% |
| Total Depreciation and Amortization | -10.19% | -8.75% | 4.33% | -6.71% | 0.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.16% | 6.13% | 74.94% | 41.21% | 6.38% |
| Change in Net Operating Assets | -146.31% | 318.07% | -18.36% | -1,223.54% | 150.60% |
| Cash from Operations | -37.76% | 0.84% | -10.13% | -48.99% | 3.48% |
| Capital Expenditure | 5.68% | -278.89% | -172.02% | 19.27% | 11.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 133.40% | -52.90% | -5.71% | 114.20% | -443.67% |
| Cash from Investing | 132.95% | -54.28% | -7.32% | 114.05% | -434.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.42% | -55.97% | -96.65% | 25.87% | -2.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.42% | -55.97% | -96.65% | 25.87% | -2.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 143.29% | -159.45% | -58.92% | 82.18% | -124.08% |